Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery Post author: Post published:March 20, 2024 Post category:uncategorized Post Content You Might Also Like Mount Sinai launches AI center to revolutionize small molecule drug discovery April 2, 2025 Researchers develop a computational model of grid cell-mediated episodic encoding January 16, 2025 Breast cancer patients struggle with several unmet emotional and financial concerns October 20, 2024